* Erytech completes patient enrollment in phase 2 trial of
eryaspase (graspa) for pancreatic cancer
The post BRIEF-Erytech completes patient enrollment in phase 2 trial of eryaspase (graspa) for pancreatic cancer appeared first on NASDAQ.
BRIEF-Erytech completes patient enrollment in phase 2 trial of eryaspase (graspa) for pancreatic cancer
